A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
Condition(s):HypertensionLast Updated:February 7, 2017Completed
Hide Studies Not Open or Pending
Condition(s):HypertensionLast Updated:February 7, 2017Completed
Condition(s):HypertensionLast Updated:April 21, 2014Completed
Condition(s):Obesity, MorbidLast Updated:April 13, 2023Recruiting
Condition(s):HealthyLast Updated:October 28, 2014Completed
Condition(s):HypertensionLast Updated:April 15, 2011Completed
Condition(s):HypertensionLast Updated:April 15, 2011Completed
Condition(s):HypertensionLast Updated:March 25, 2022Completed
Condition(s):Essential HypertensionLast Updated:January 10, 2019Completed
Condition(s):HypertensionLast Updated:November 8, 2011Completed
Condition(s):Essential HypertensionLast Updated:December 24, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.